To explore the pathogenic mechanisms underlying ApoA4 regulation of liver steatosis through liver immune cells, we performed scRNA-seq to profile the reprogramming of the liver immune microenvironment from the two groups of mice. This evidence concerns the gene APOA4 and fatty liver disease.